⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28585364 | 0.75 | — | — | |
| SCHEMBL28275957 | 0.75 | — | — | |
| SCHEMBL11402674 | 0.75 | — | — | |
| SCHEMBL3718214 | 0.71 | — | — | |
| SCHEMBL27577447 | 0.71 | — | — | |
| SCHEMBL28449513 | 0.71 | — | — | |
| SCHEMBL3226130 | 0.65 | — | — | |
| SCHEMBL5810451 | 0.62 | — | — | |
| SCHEMBL107641 | 0.62 | PTK2 (1.00) | — | |
| SCHEMBL21000942 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002323-A1 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES | KREOS CAPITAL VII (UK) LIMITED (GB) | 2023-01-05 | — | — | US | disclosed |
| EP-4026829-A1 | PROCESS FOR PREPARING N-[[5-(3-CHLOROPHENYL)-3-HYDROXY-2-PYRIDINYL]CARBONYL]-GLYCINE FROM 5-(3-CHLOROPHENYL)-3-HYDROXY-2-PYRIDINE CARBOXYLIC ACID | Akebia Therapeutics Inc. (US) | 2022-07-13 | — | — | EP | disclosed |
| US-11267785-B2 | Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides | AKEBIA THERAPEUTICS, INC. (US) | 2022-03-08 | — | — | US | disclosed |
| EP-3683209-B1 | PROCESS FOR PREPARING [(5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL)-AMINO]ACETIC ACID FROM 5-((3-CHLOROPHENYL)-3-CHLORO-PYRIDIN-2-YL)-NITRILE, AND PROCESS FOR PREPARING 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRILE DERIVATIVES | AKEBIA THERAPEUTICS INC (US) | 2021-11-10 | — | — | EP | disclosed |
| US-20210122715-A1 | PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES | KREOS CAPITAL VII (UK) LIMITED (GB) | 2021-04-29 | — | — | US | disclosed |
| US-10751645-B2 | Chromatography ligand | GE HEALTHCARE BIOPROCESS R&D AB (SE) | 2020-08-25 | — | — | US | disclosed |
| US-10738010-B2 | Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides | AKEBIA THERAPEUTICS, INC. (US) | 2020-08-11 | — | — | US | disclosed |
| EP-3683209-A1 | PROCESS FOR PREPARING [(5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL)-AMINO]ACETIC ACID FROM 5-((3-CHLOROPHENYL)-3-CHLORO-PYRIDIN-2-YL)-NITRILE, AND PROCESS FOR PREPARING 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRILE DERIVATIVES | Akebia Therapeutics Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| EP-2513142-B1 | MEMBRANES AND ASSOCIATED METHODS FOR PURIFICATION OF ANTIBODIES | GEN ELECTRIC (US) | 2019-04-10 | — | — | EP | disclosed |
| US-10246416-B2 | Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides | AKEBIA THERAPEUTICS, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-6702943-B1 | CONTACTING LIQUID WITH MATRIX CARRYING LIGANDS COMPRISING A POSITIVELY CHARGED STRUCTURE AND HYDROPHOBIC STRUCTURE, DESORBING SUBSTANCE | AMERSHAM BIOSCIENCES AB (SE) | 2004-03-09 | — | — | US | disclosed |
| US-20040020857-A1 | Method for mixed mode adsorption and mixed mode adsorbents | CYTIVA BIOPROCESS R&D AB (SE) | 2004-02-05 | — | — | US | disclosed |
| EP-1345695-A2 | A METHOD FOR MIXED MODE ADSORPTION AND MIXED MODE ADSORBENTS | Amersham Biosciences AB (SE) | 2003-09-24 | — | — | EP | disclosed |
| EP-1345694-A2 | A METHOD FOR THE MANUFACTURE OF COMPOSITIONS CONTAINING LOW CONCENTRATIONS OF SALTS | Amersham Biosciences AB (SE) | 2003-09-24 | — | — | EP | disclosed |
| EP-1235748-A2 | A METHOD FOR ANION-EXCHANGE ADSORPTION AND ANION-EXCHANGERS | Amersham Biosciences AB (SE) | 2002-09-04 | — | — | EP | disclosed |
| EP-1235749-A1 | A METHOD FOR ANION-EXCHANGE ADSORPTION AND THIOETHER ANION-EXCHANGERS | Amersham Biosciences AB (SE) | 2002-09-04 | — | — | EP | disclosed |
| WO-2002053252-A2 | A METHOD FOR MIXED MODE ADSORPTION AND MIXED MODE ADSORBENTS | AMERSHAM BIOSCIENCES AB (SE) | 2002-07-11 | — | — | WO | disclosed |
| WO-2002053288-A2 | A METHOD FOR THE MANUFACTURE OF COMPOSITIONS CONTAINING LOW CONCENTRATIONS OF SALTS | AMERSHAM BIOSCIENCES AB (SE) | 2002-07-11 | — | — | WO | disclosed |
| WO-2001038227-A2 | A METHOD FOR ANION-EXCHANGE ADSORPTION AND ANION-EXCHANGERS | AMERSHAM BIOSCIENCES AB (SE) | 2001-05-31 | — | — | WO | disclosed |
| WO-2001038228-A1 | A METHOD FOR ANION-EXCHANGE ADSORPTION AND THIOETHER ANION-EXCHANGERS | AMERSHAM BIOSCIENCES AB (SE) | 2001-05-31 | — | — | WO | disclosed |